Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST)

Historical Holders from Q3 2023 to Q4 2024

Symbol
ACST
CUSIP
00430K865
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
15M
All holders as of December 31, 2024
Q4 2024
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-11
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADAR1 Capital Management, LLC 9.99% 1.5M ADAR1 Capital Management GP, LLC Mar 31, 2025

Institutional Holders of Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 0 $0 -$3.48M 0
2024 Q3 1.16M $3.48M -$2.9M $3.00 11
2024 Q2 2.15M $6.3M -$18.9K $2.93 12
2024 Q1 14.5K $50.4K -$64.1K $3.42 3
2023 Q4 571K $1.65M +$57.7K $2.89 8
2023 Q3 518K $1.44M +$1.44M $2.78 7